Cell-specific imaging of reporter gene expression using a two-step transcriptional amplification strategy

Molecular Imaging with Reporter Genes

Volumn , Issue , 2010, Pages 127-148

  Figueiredo, Marxa L ^a   Gambhir, Sanjiv Sam ^b   Carey, Michael ^c   Wu, Lily ^c  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOASSAY; BIOLUMINESCENCE; CYTOLOGY; FLUORESCENCE; GENE THERAPY; MAGNETIC RESONANCE IMAGING; PARTICLE BEAMS; PLANTS (BOTANY); POSITRON EMISSION TOMOGRAPHY; TISSUE; TRANSCRIPTION; VIRUSES;

AMPLIFICATION STRATEGY; GREEN FLUORESCENT PROTEIN; MAGNETIC RESONANCE IMAGING (MRI); NON-INVASIVE MONITORING; POSITRON EMISSION TOMOGRAPHY (PET); REPORTER-GENE EXPRESSION; TRANSCRIPTIONAL ACTIVITY; TRANSCRIPTIONAL TARGETING;

SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

EID: 79955787256     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511730405.007     Document Type: Chapter

References (59)

1. Ray, P., Bauer, E., Iyer, M., Barrio, J. R., Satyamurthy, N., Phelps, M. E. et al. (2001). Monitoring gene therapy with reporter gene imaging. Semin Nucl Med 31(4): 312-320
2. Wu, L., Johnson, M., Sato, M. (2003). Transcriptionally targeted gene therapy to detect and treat cancer. Trends Mol Med 9(10): 421-429
3. Wu, L., Matherly, J., Smallwood, A., Adams, J. Y., Billick, E., Belldegrun, A. et al. (2001). Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors. Gene Ther 8(18): 1416-1426
4. Lee, S. J., Kim, H. S., Yu, R., Lee, K., Gardner, T. A., Jung, C. et al. (2002). Novel prostate-specific promoter derived from PSA and PSMA enhancers. Mol Ther 6(3): 415-421
5. Sadowski, I., Ma, J., Triezenberg, S., Ptashne, M. (1988). GAL4-VP16 is an unusually potent transcriptional activator. Nature 335(6190): 563-564
6. Segawa, T., Takebayashi, H., Kakehi, Y., Yoshida, O., Narumiya, S., Kakizuka, A. (1998). Prostate-specific amplification of expanded polyglutamine expression: a novel approachfor cancer gene therapy. Cancer Res 58(11): 2282-2287
7. Figueiredo, M. L., Sato, M., Johnson, M., Wu, L. (2006). Specific targeting of gene therapy to prostate cancer using a two-step transcriptional amplification system. Future Oncol 2(3): 391-406
8. Aumuller, G., Seitz, J., Lilja, H., Abrahamsson, P. A., von der Kammer, H., Scheit, K.H. (1990). Species-and organ-specificity of secretory proteins derived fromhuman prostate and seminal vesicles. Prostate 17(1): 31-40
9. Zhang, L., Adams, J. Y., Billick, E., Ilagan, R., Iyer, M., Le, K. et al. (2002). Molecular engineering of a two-step transcription amplification (TSTA) system for transgene delivery in prostate cancer. Mol Ther 5(3): 223-232
10. Cleutjens, K. B., van der Korput, H. A., Ehren-van Eekelen, C. C., Sikes, R. A., Fasciana, C., Chung, L.W. et al. (1997). A 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans. Mol Endocrinol 11(9): 1256-1265
11. Cleutjens, K. B., van der Korput, H. A., van Eekelen, C. C., van Rooij, H. C., Faber, P. W., Trapman, J. (1997). An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. Mol Endocrinol 11(2): 148-161
12. Schaffner, D. L., Barrios, R., Shaker, M. R., Rajagopalan, S., Huang, S. L., Tindall, D. J. et al. (1995). Transgenic mice carrying a PSArasT24 hybrid gene develop salivary gland and gastrointestinal tract neoplasms. Lab Invest 72(3): 283-290
13. Yeung, F., Li, X., Ellett, J., Trapman, J., Kao, C., Chung, L.W. (2000). Regions of prostate-specific antigen (PSA) promoter confer androgen-independent expression of PSA in prostate cancer cells. J Biol Chem 275(52): 40846-40855
14. Titus, M. A., Schell, M. J., Lih, F. B., Tomer, K. B., Mohler, J. L. (2005). Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer. Clin Cancer Res 11(13): 4653-4657
15. Zhang, L., Johnson, M., Le, K. H., Sato, M., Ilagan, R., Iyer, M. et al. (2003). Interrogating androgen receptor function in recurrent prostate cancer. CancerRes 63(15): 4552-4560
16. Sato, M., Johnson, M., Zhang, L., Gambhir, M. Carey and L. Wu (2005). Functionality of androgen receptor-based gene expression imaging in hormone refractory prostate cancer. Clin Cancer Res 11(10): 3743-3749
17. Pang, S., Dannull, J., Kaboo, R., Xie, Y., Tso, C. L., Michel, K. et al. (1997). Identification of a positive regulatory element responsible for tissue-specific expression of prostatespecific antigen. Cancer Res 57(3): 495-499
18. Adams, J. Y., Johnson, M., Sato, M., Berger, F., Gambhir, S. S., Carey, M. et al. (2002). Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging. Nat Med 8(8): 891-897
19. Iyer, M., Wu, L., Carey, M., Wang, Y., Smallwood, A., Gambhir, S. S. (2001). Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters. Proc Natl Acad Sci U S A 98(25): 14595-14600
20. Qiao, J., Doubrovin, M., Sauter, B. V., Huang, Y., Guo, Z. S., Balatoni, J. et al. (2002). Tumor-specific transcriptional targeting of suicide gene therapy. Gene Ther 9(3): 168-175
21. Sato, M., Johnson, M., Zhang, L., Zhang, B., Le, K., Gambhir, S. S. et al. (2003). Optimization of adenoviral vectors to direct highly amplified prostate-specific expression for imaging and gene therapy. Mol Ther 8(5): 726-737
22. Johnson, M., Sato, M., Burton, J., Gambhir, S. S., Carey, M., Wu, L. (2005). Micro-PET/CT monitoring of herpes thymidine kinase suicide gene therapy in a prostate cancer xenograft: The advantage of a cell-specific transcriptional targeting approach. Mol Imaging 4(4): 463-472
23. Ilagan, R., Zhang, L. J., Pottratz, J., Le, K., Salas, S., Iyer, M. et al. (2005). Imaging androgen receptor function during flutamide treatment in the LAPC9 xenograft model. Mol Cancer Ther 4(11): 1662-1669
24. Johnson, M., Huyn, S., Burton, J., Sato, M., Wu, L. (2006). Differential biodistribution of adenoviral vector in vivo as monitored by bioluminescence imaging and quantitative polymerase chain reaction. Hum Gene Ther 17(12): 1262-1269
25. Sato, M., Figueiredo, M. L., Burton, J. B., Johnson, M., Chen, M., Powell, R. et al. (2008). Configurations of a two-tiered amplified gene expression system in adenoviral vectors designed to improve the specificity of in vivo prostate cancer imaging. Gene Ther 15(8): 583-593
26. Ray, S., Paulmurugan, R., Hildebrandt, I., Iyer, M., Wu, L., Carey, M. et al. (2004). Novel bidirectional vector strategy for amplification of therapeutic and reporter gene expression. HumGene Ther 15(7): 681-690
27. Ray, S., Paulmurugan, R., Patel, M. R., Ahn, B. C., Wu, L., Carey, M. et al. (2008). Noninvasive imaging of therapeutic gene expression using a bidirectional transcriptional amplification strategy. Mol Ther
28. Iyer, M., Salazar, F. B., Lewis, X., Zhang, L., Carey, M., Wu, L. et al. (2004).Noninvasive imaging of enhanced prostatespecific gene expression using a two-step transcriptional amplification-based lentivirus vector. Mol Ther 10(3): 545-552
29. Iyer, M., Salazar, F. B., Wu, L., Carey, M., Gambhir, S. S. (2006). Bioluminescence imaging of systemic tumor targeting using a prostate-specific lentiviral vector. Hum Gene Ther 17(1): 125-132
30. Wang, Y., Iyer, M., Annala, A., Wu, L., Carey, M., Gambhir, S. S. (2006). Noninvasive indirect imaging of vascular endothelial growth factor gene expression using bioluminescence imaging in living transgenic mice. Physiol Genomics 24(2): 173-180
31. Ilagan, R., Pottratz, J., Le, K., Zhang, L., Wong, S. G., Ayala, R. et al. (2006). Imaging mitogen-activated protein kinase function in xenograftmodels of prostate cancer. Cancer Res 66(22): 10778-10785
32. Massoud, T. F., Gambhir, S. S. (2003). Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17(5): 545-580
33. Iyer, M., Sato, M., Johnson, M., Gambhir, S. S., Wu, L. (2005). Applications of molecular imaging in cancer gene therapy. Curr Gene Ther 5(6): 607-618
34. Brakenhielm, E., Burton, J. B., Johnson, M., Chavarria, N., Morizono, K., Chen, I. et al. (2007).Modulating metastasis by a lymphangiogenic switch in prostate cancer. Int JCancer 121(10): 2153-2161
35. Burton, J. B., Johnson, M., Sato, M., Koh, S. B., Mulholland, D. J., Stout, D. et al. (2008). Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer. Nat Med 14(8): 882-888
36. Block, A., Milasinovic, D., Mueller, J., Schaefer, P., Schaefer, H., Greten, H. (2002). Amplified Muc1-specific gene expression in colon cancer cells utilizing a binary system in adenoviral vectors. Anticancer Res 22(6A): 3285-3292
37. Xie, X., Xia, W., Li, Z., Kuo, H. P., Liu, Y., Ding, Q. et al. (2007). Targeted expression of BikDDeradicates pancreatic tumors in noninvasive imaging models. Cancer Cell 12(1): 52-65
38. Richards, C. A., Austin, E. A., Huber, B. E. (1995). Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumor-specific gene therapy. Hum Gene Ther 6(7): 881-893
39. Siders, W. M., Halloran, P. J., Fenton, R. G. (1998). Melanoma-specific cytotoxicity induced by a tyrosinase promoter-enhancer/herpes simplex virus thymidine kinase adenovirus. Cancer Gene Ther 5(5): 281-291
40. Koch, P. E., Guo, Z. S., Kagawa, S., Gu, J., Roth, J. A., Fang, B. (2001). Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory system. Mol Ther 3(3): 278-283
41. Zhang, D., Sutanto, E.N., Rakoczy, P. E. (2004).Concurrent enhancement of transcriptional activity and specificity of a retinal pigment epithelial cell-preferential promoter. Mol Vis 10: 208-214
42. Dzojic, H., Cheng, W. S., Essand, M. (2007). Two-step amplification of the human PPT sequence provides specific gene expression in an immunocompetent murine prostate cancer model. Cancer Gene Ther 14(3): 233-240
43. Woraratanadharm, J., Rubinchik, S., Yu, H., Fan, F., Morrow, S.M., Dong, J. Y. (2004).Highly specific transgene expression mediated by a complex adenovirus vector incorporating a prostate-specific amplification feedback loop. Gene Ther 11(18): 1399-1407
44. Sato, Y., Tanaka, K., Lee, G., Kanegae, Y., Sakai, Y., Kaneko, S. et al. (1998). Enhanced and specific gene expression via tissue-specific production of Cre recombinase using adenovirus vector. Biochem Biophys Res Commun 244(2): 455-462
45. Yoshimura, I., Ikegami, S., Suzuki, S., Tadakuma, T., Hayakawa, M. (2002). Adenovirus mediated prostate specific enzyme prodrug gene therapy using prostate specific antigen promoter enhanced by the Cre-loxP system. J Urol 168(6): 2659-2664
46. Ikegami, S., Tadakuma, T., Suzuki, S., Yoshimura, I., Asano, T., Hayakawa, M. (2002). Development of gene therapy using prostate-specific membrane antigen promoter/enhancer with Cre Recombinase/LoxP system for prostate cancer cells under androgen ablation condition. Jpn J Cancer Res 93(10): 1154-1163
47. Ikegami, S., Tadakuma, T., Ono, T., Suzuki, S., Yoshimura, I., Asano, T. et al. (2004). Treatment efficiency of a suicide gene therapy using prostate-specific membrane antigen promoter/enhancer in a castratedmouse model of prostate cancer. Cancer Sci 95(4): 367-370
48. Kaczmarczyk, S. J., Green, J. E. (2003). Induction of cre recombinase activity using modified androgen receptor ligand binding domains: a sensitive assay for ligand-receptor interactions. Nucleic Acids Res 31(15): e86
49. Sundaresan, G., Paulmurugan, R., Berger, F., Stiles, B., Nagayama, Y., Wu, H. et al. (2004). MicroPET imaging of Cre-loxP-mediated conditional activation of a herpes simplex virus type 1 thymidine kinase reporter gene. Gene Ther 11(7): 609-618
50. Koster, R.W., Fraser, S. E. (2001).Tracing transgene expression in living zebrafish embryos. Dev Biol 233(2): 329-346
51. Loonstra, A., Vooijs, M., Beverloo, H. B., Allak, B. A., van Drunen, E., Kanaar, R. et al. (2001). Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc Natl Acad Sci U S A 98(16): 9209-9214
52. Wang, H.U., Chen, Z. F., Anderson, D. J. (1998).Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93(5): 741-753
53. Braselmann, S., Graninger, P., Busslinger, M. (1993). A selective transcriptional induction system for mammalian cells based on Gal4-estrogen receptor fusion proteins. Proc Natl Acad Sci U S A 90(5): 1657-1661
54. Rivera, V.M., Clackson, T., Natesan, S., Pollock, R., Amara, J. F., Keenan, T. et al. (1996). A humanized system for pharmacologic control of gene expression. Nat Med 2(9): 1028-1032
55. Pollock, R., Clackson, T. (2002). Dimerizer-regulated gene expression. Curr Opin Biotechnol 13(5): 459-467
56. Nguyen, M., Huan-Tu, G., Gonzalez-Edick, M., Rivera, V. M., Clackson, T., Jooss, K.U. et al. (2007). Rapamycinregulated control of antiangiogenic tumor therapy following rAAV-mediated gene transfer. Mol Ther 15(5): 912-920
57. Stevenson, M., Hale, A. B., Hale, S. J., Green, N. K., Black, G., Fisher, K. D. et al. (2007). Incorporation of a laminin-derived peptide (SIKVAV) on polymer-modified adenovirus permits tumor-specific targeting via alpha6-integrins. Cancer Gene Ther 14(4): 335-345
58. Bonsted, A., Engesaeter, B. O., Hogset, A., Maelandsmo, G. M., Prasmickaite, L., D’Oliveira, C. et al. (2006). Photochemically enhanced transduction of polymer-complexed adenovirus targeted to the epidermal growth factor receptor. J Gene Med 8(3): 286-297
59. Kraaij, R., van Rijswijk, A. L., Oomen, M. H., Haisma H. J., Bangma, C. H. (2005). Prostate specific membrane antigen (PSMA) is a tissue-specific target for adenoviral transduction of prostate cancer in vitro. Prostate 62(3): 253-259.